N. Hudson et al., ENHANCED GASTRIC-MUCOSAL LEUKOTRIENE-B(4) SYNTHESIS IN PATIENTS TAKING NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Gut, 34(6), 1993, pp. 742-747
The effects of longstanding non-steroidal anti-inflammatory drug (NSAI
D) treatment on gastric mucosal synthesis of leukotriene B4 (LTB4), le
ukotriene C4 (LTC4), and prostaglandin E2 (PGE2) was studied. Gastric
antral biopsies in 65 patients with arthritis taking NSAIDs and 23 con
trol patients were taken and eicosanoid concentrations, stimulated by
vortex mixing or calcium ionophore, were measured by radioimmunoassay.
Median gastric mucosal synthesis of LTB4 was increased in patients ta
king NSAIDs compared with non-users: (0.9 (0.2-2.5) pg/mg upsilon 0 (0
-0.6) pg/mg (p<0.001)). These differences persisted when subgroups of
patients were analysed according to Helicobacter pylori colonisation o
r degree of mucosal injury. Synthesis of LTB4 was strongly associated
with the presence of type C (chemical) gastritis. Increased synthesis
of LTC4 was associated with Helicobacter pylori colonisation but not N
SAID use. Synthesis of PGE2 was decreased in patients taking NSAIDs co
mpared with control patients (p<0.001). Enhanced gastric mucosal synth
esis of LTB4 in patients taking NSAIDs may represent a primary effect
of these drugs and could be implicated in the pathogenesis of gastriti
s and ulceration associated with NSAIDs.